Repurposing drugs in oncology: From candidate selection to clinical adoption
https://www.sciencedirect.com/science/article/pii/S1044579X20300110
Table 1. Osteosarcoma repurposing candidates and mechanisms of action.
Mechanism of ActionDrug (main indication)Type of evidenceCell differentiationCytotoxicity & potentiation of chemotherapyStem cells cytotoxictyImmunomodulationEpigenetic modificationsCell-cell interaction
Calcitriol (vitamin D deficiency) | Animal model |
Simvastatin (hypercholesterolemia) | Animal model |
Glucocorticoids (inflammation) | Animal model |
Caffeine (infant apnea) | Human trial / Animal model |
Esomeprazole (peptic ulcer) | Human trial / Animal model |
Verapamil (hypertension) | Case reports / In vitro |
Piroxicam (osteoarthritis) | Canine trials / Animal model |
Metformin (type 2 diabetes) | Animal model |
Disulfiram (alcohol dependency) | In vitro |
Sirolimus (prevention organ rejection) | Human trial / Animal model |
Valproic acid (epilepsy) | Animal model |
Aspirin (CVD prevention) | Animal model |
Heparin (VTE) | Animal model |
Warfarin (embolisation) | Human trial / Animal model |
Plerixafor (stem cell mobilization) | Animal model |
CVD – cardiovascular diseases; VTE – venous thromboembolism.
'암치료' 카테고리의 다른 글
Epidrug repurposing (0) | 2021.08.22 |
---|---|
약물 용도 변경으로 암 치료 병목 극복 (0) | 2021.08.22 |
암의 미토콘드리아 에너지 대사를 표적으로 하는 약물 용도 변경 (0) | 2021.08.22 |
The Repurposing Drugs in Oncology (ReDO) Project (0) | 2021.08.22 |
표적 DNA 손상 복구 및 반응 경로를 목적으로 하는 소분자 약물 (0) | 2021.08.22 |